Key result
Prophylactic administration of low-dose colchicine for 1 month prevents the development of post-cardiac injury syndrome after cardiac surgery, despite some adverse effects.
Why the study?
Post-cardiac injury syndrome is associated with prolonged hospitalization, invasive interventions, and higher mortality after cardiac surgery, supporting the need for effective prophylaxis.
Does low-dose postoperative colchicine prevent post-cardiac injury syndrome in patients after cardiac surgery?
Does low-dose postoperative colchicine prevent post-cardiac injury syndrome in patients after cardiac surgery?
Low-dose postoperative administration of colchicine for 1 month should be considered after cardiac surgery to prevent PCIS, supporting current ESC guidelines.
May warrant consideration post-cardiac surgery; leaves open confirmation in prospective RCTs.
Prevention of post-cardiac injury syndrome after cardiac surgery The post-cardiac injury syndrome (PCIS) is a major cause of pericarditis after cardiac surgery, myocardial infarction or chest trauma. PCIS is an immune-mediated inflammatory process as a result of cardiac tissue damage with antigen exposure. The clinical presentation is variable, but systemic inflammation is required for the diagnosis. PCIS is associated with prolonged hospitalization, invasive interventions and a higher mortality rate, especially in case of invasive cardiac surgery, which supports the use of prophylaxis. Research with methylprednisolone, aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) shows no protective effect. However, prophylactic administration of colchicine prevents the development of PCIS, at the expense of some adverse effects. Low-dose postoperative administration of colchicine during 1 month should be considered after cardiac surgery to prevent PCIS (guidelines IIA of the European Society of Cardiology (ESC)). Therapeutic cardiac lymphangiogenesis, in which a higher clearance of inflammatory cells is obtained, is a potential future method for the prevention of PCIS, but this needs more study.
No takes yet. Share an insight, caveat, or question.
Delaet et al. (2022) conducted a review in Post-cardiac injury syndrome (PCIS). Colchicine was evaluated on Development of PCIS. Prophylactic administration of low-dose colchicine for 1 month prevents the development of post-cardiac injury syndrome after cardiac surgery, despite some adverse effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: